Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Metabolic Syndrome × Diet × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Motor Activity 11 Polycystic Ovary Syndrome 8 Obesity 7 Breast Neoplasms 6 Colorectal Neoplasms 5 Colonic Neoplasms 4 Weight Loss 3 Prostatic Neoplasms 3 Multiple Endocrine Neoplasia Type 1 3 Endometrial Neoplasms 3 Pancreatic Neoplasms 2 Overweight 2 Neoplasms 2 Malnutrition 2 Lymphoma, Follicular 2 Lymphoma 2 Carcinoma, Intraductal, Noninfiltrating 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sexual Dysfunction, Physiological 1 Sarcopenia 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Compliance 1 Pancreatitis, Chronic 1 Ovarian Neoplasms 1 Myelodysplastic Syndromes 1 Metabolic Syndrome 1

Interventions

Metformin 7 Magnetic Resonance Spectroscopy 2 Inositol 2 Exercise 2 maltodextrin 1 Walking 1 Triptorelin Pamoate 1 Spironolactone 1 Pyruvic Acid 1 Pioglitazone 1 Phlebotomy 1 Pancreaticoduodenectomy 1 Orchiectomy 1 Leuprolide 1 Hepatectomy 1 Ethinyl Estradiol 1 Etanercept 1 Estrogens 1 Diet, Reducing 1 Diet, Mediterranean 1 Diet, Fat-Restricted 1 Diet Therapy 1 Diet 1 Diathermy 1 Cyproterone Acetate 1 Contraceptives, Oral 1 Continuous Positive Airway Pressure 1 Caloric Restriction 1 Bloodletting 1 Blood Pressure 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03173807 2017-10-06

ProNEST

University of Pittsburgh

Phase NA Withdrawn

Prostatic Neoplasms, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡